This interesting research in mice at U Chicago Medical center uses CRISPR to express, in skin grafts, a glucagon-like peptide, GLP1, which stimulates insulin production:
Far from human application but interesting: if it ever works on humans you could treat Type 2 diabetes with skin grafts, at least for a time.